Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
-246.42%EBIT Margin
VS
Market
Sector
Industry
History
$ 0.2Close
$ 0.04 - $ 0.84 52-Week Range
Ticker Information
Ticker
ADAPCompany Name
ADAPTIMMUNE THERAPEUTICS PLCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQADAPTIMMUNE THERAPEUTICS PLC - EBIT Margin Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
ADAP - EBIT % Historical data
| Date | Earning Before Interest & Taxes (EBIT) | EBIT Margin | Revenues |
|---|---|---|---|
| 6/30/2025 | $ -160.38M | -246.42% | $ 65.08M |
| 3/31/2025 | $ -61.04M | -33.98% | $ 179.64M |
| 12/31/2024 | $ -63.89M | -35.89% | $ 178.03M |
| 9/30/2024 | $ -41.65M | -23.8% | $ 175.04M |
| 6/30/2024 | $ -70.89M | -50.11% | $ 141.46M |
| 3/31/2024 | $ -162.17M | -883.39% | $ 18.36M |
| 12/31/2023 | $ -112.53M | -186.68% | $ 60.28M |
| 9/30/2023 | $ -92.22M | -129.74% | $ 71.08M |
| 6/30/2023 | $ -88.33M | -124.81% | $ 70.77M |
| 3/31/2023 | $ -111.67M | -156.89% | $ 71.17M |
Key Performance Insights, Last 5 Years
- ADAPTIMMUNE THERAPEUTICS PLC's latest trailing twelve months (TTM) EBIT % stands at -3851.92%.
- Over the past 5 years, ADAPTIMMUNE THERAPEUTICS PLC's average EBIT % has been -1258.79%.
- The median EBIT % for ADAPTIMMUNE THERAPEUTICS PLC during this period was -741.83%
- ADAPTIMMUNE THERAPEUTICS PLC reached its highest EBIT % over the past 5 years at -23.8%.
- The lowest EBIT % recorded by ADAPTIMMUNE THERAPEUTICS PLC in the same timeframe -3851.92%
ADAPTIMMUNE THERAPEUTICS PLC's EBIT % vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
EBIT % Benchmarks
Similar metrics to Revenues:
- EBITDA Margin - [Calculation] A company’s [EBITDA] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest, taxes, depreciation and amortization.
- Net Margin - [Calculation] A company’s Net Income [NetIncCmn] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated.
- Free Cash Flow Margin - [Calculation] A company’s Free Cash Flow [FCF] as a percentage of [Revenue]. Measures how much cash a company produces for each dollar of revenue generated.
- Revenues - [Income Statement] The sum of revenue generated from all sold goods and rendered services.
- Operating Margin - [Calculation] A company’s operating income [OpInc] as a percentage of [Revenue]. The operating margin measures how much profit a company produces for each dollar of revenue generated, after paying for variable costs such as wages and raw materials.
Definition of EBIT Margin
[Calculation] A company’s [EBIT] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest and taxes.EBIT / Revenues
(=) EBIT % EBIT % for ADAPTIMMUNE THERAPEUTICS PLC is calculated as follows: EBIT [ $ -122.64M ] / Revenues [ $ 3.18M ]
(=) EBIT % [ -3851.92% ] ADAP - EBIT Margin, Last 5 years
-3851.92%
Minimum
Sep 30, 2020
-23.8%
Maximum
Sep 30, 2024
-1258.79%
Average
-741.83%
Median
EBIT % Benchmark AnalysisMarket
The chart above depicts the distribution of EBIT % for companies in the Total Stock Market. The average EBIT % of the companies is 9.54% with a standard deviation of 23.96%.
The following table provides additional summary stats:
EBIT % in the Market:
| filtered constituents | 3.26K |
|---|---|
| min | -73.16% |
| max | 83.08% |
| average | 9.54% |
| median | 9.01% |
| std | 23.96% |